Esperion Therapeutics, Inc. financial statements, including revenue, expenses, and profit
The total revenue of ESPR for the last quarter is 69.11 M USD, and it's 33.86% higher compared to the previous quarter. The net income of Q4 24 is -21.32 M USD.